nodes	percent_of_prediction	percent_of_DWPC	metapath
Antipyrine—PTGS2—urinary bladder cancer	0.307	1	CbGaD
Antipyrine—CYP2B6—Thiotepa—urinary bladder cancer	0.0963	0.189	CbGbCtD
Antipyrine—CYP2A6—Fluorouracil—urinary bladder cancer	0.0481	0.0941	CbGbCtD
Antipyrine—PTGS2—Cisplatin—urinary bladder cancer	0.0413	0.0809	CbGbCtD
Antipyrine—PTGS2—Etoposide—urinary bladder cancer	0.0406	0.0795	CbGbCtD
Antipyrine—PTGS1—Etoposide—urinary bladder cancer	0.0343	0.0671	CbGbCtD
Antipyrine—CYP3A4—Thiotepa—urinary bladder cancer	0.0296	0.0579	CbGbCtD
Antipyrine—CYP2B6—Cisplatin—urinary bladder cancer	0.0266	0.0521	CbGbCtD
Antipyrine—CYP2E1—Etoposide—urinary bladder cancer	0.0265	0.0518	CbGbCtD
Antipyrine—CYP2C8—Fluorouracil—urinary bladder cancer	0.0237	0.0464	CbGbCtD
Antipyrine—SLC22A6—Methotrexate—urinary bladder cancer	0.0199	0.0389	CbGbCtD
Antipyrine—CYP2C8—Etoposide—urinary bladder cancer	0.0198	0.0387	CbGbCtD
Antipyrine—CYP1A2—Fluorouracil—urinary bladder cancer	0.0183	0.0359	CbGbCtD
Antipyrine—CYP2B6—Doxorubicin—urinary bladder cancer	0.0178	0.0349	CbGbCtD
Antipyrine—CYP2C9—Fluorouracil—urinary bladder cancer	0.0165	0.0324	CbGbCtD
Antipyrine—CYP1A2—Etoposide—urinary bladder cancer	0.0153	0.03	CbGbCtD
Antipyrine—CYP2C9—Cisplatin—urinary bladder cancer	0.014	0.0275	CbGbCtD
Antipyrine—CYP2D6—Doxorubicin—urinary bladder cancer	0.00861	0.0169	CbGbCtD
Antipyrine—CYP3A4—Etoposide—urinary bladder cancer	0.00802	0.0157	CbGbCtD
Antipyrine—TRPA1—prostate gland—urinary bladder cancer	0.00675	0.116	CbGeAlD
Antipyrine—CYP3A4—Doxorubicin—urinary bladder cancer	0.00547	0.0107	CbGbCtD
Antipyrine—TRPA1—renal system—urinary bladder cancer	0.0046	0.0791	CbGeAlD
Antipyrine—CYP2C19—urine—urinary bladder cancer	0.00387	0.0666	CbGeAlD
Antipyrine—CYP1A2—urine—urinary bladder cancer	0.00316	0.0544	CbGeAlD
Antipyrine—CYP2C9—urine—urinary bladder cancer	0.003	0.0516	CbGeAlD
Antipyrine—CYP2E1—urine—urinary bladder cancer	0.00284	0.0489	CbGeAlD
Antipyrine—CYP3A4—urine—urinary bladder cancer	0.00229	0.0394	CbGeAlD
Antipyrine—CYP2D6—urine—urinary bladder cancer	0.00225	0.0387	CbGeAlD
Antipyrine—CYP2A6—prostate gland—urinary bladder cancer	0.00216	0.0372	CbGeAlD
Antipyrine—CYP2A6—seminal vesicle—urinary bladder cancer	0.00183	0.0314	CbGeAlD
Antipyrine—CYP2C18—vagina—urinary bladder cancer	0.00161	0.0278	CbGeAlD
Antipyrine—CYP2A6—vagina—urinary bladder cancer	0.00107	0.0183	CbGeAlD
Antipyrine—CYP2E1—prostate gland—urinary bladder cancer	0.00102	0.0176	CbGeAlD
Antipyrine—PTGS1—prostate gland—urinary bladder cancer	0.000984	0.0169	CbGeAlD
Antipyrine—PTGS2—prostate gland—urinary bladder cancer	0.00094	0.0162	CbGeAlD
Antipyrine—CYP2E1—seminal vesicle—urinary bladder cancer	0.000864	0.0149	CbGeAlD
Antipyrine—PTGS1—seminal vesicle—urinary bladder cancer	0.000832	0.0143	CbGeAlD
Antipyrine—CYP2C8—renal system—urinary bladder cancer	0.000827	0.0142	CbGeAlD
Antipyrine—PTGS2—seminal vesicle—urinary bladder cancer	0.000795	0.0137	CbGeAlD
Antipyrine—CYP1A2—renal system—urinary bladder cancer	0.000774	0.0133	CbGeAlD
Antipyrine—CYP2B6—renal system—urinary bladder cancer	0.000742	0.0128	CbGeAlD
Antipyrine—PTGS1—epithelium—urinary bladder cancer	0.000723	0.0124	CbGeAlD
Antipyrine—PTGS1—smooth muscle tissue—urinary bladder cancer	0.000697	0.012	CbGeAlD
Antipyrine—CYP2E1—renal system—urinary bladder cancer	0.000696	0.012	CbGeAlD
Antipyrine—PTGS2—epithelium—urinary bladder cancer	0.000691	0.0119	CbGeAlD
Antipyrine—CYP2C19—vagina—urinary bladder cancer	0.000686	0.0118	CbGeAlD
Antipyrine—CYP2E1—urethra—urinary bladder cancer	0.000684	0.0118	CbGeAlD
Antipyrine—PTGS1—renal system—urinary bladder cancer	0.000671	0.0115	CbGeAlD
Antipyrine—PTGS2—smooth muscle tissue—urinary bladder cancer	0.000666	0.0114	CbGeAlD
Antipyrine—CYP2C8—female reproductive system—urinary bladder cancer	0.000662	0.0114	CbGeAlD
Antipyrine—PTGS2—renal system—urinary bladder cancer	0.000641	0.011	CbGeAlD
Antipyrine—PTGS2—urethra—urinary bladder cancer	0.00063	0.0108	CbGeAlD
Antipyrine—CYP2C8—vagina—urinary bladder cancer	0.000599	0.0103	CbGeAlD
Antipyrine—CYP2B6—female reproductive system—urinary bladder cancer	0.000594	0.0102	CbGeAlD
Antipyrine—CYP2C9—female reproductive system—urinary bladder cancer	0.000588	0.0101	CbGeAlD
Antipyrine—CYP3A4—renal system—urinary bladder cancer	0.00056	0.00963	CbGeAlD
Antipyrine—CYP2E1—female reproductive system—urinary bladder cancer	0.000557	0.00958	CbGeAlD
Antipyrine—CYP2D6—renal system—urinary bladder cancer	0.000551	0.00948	CbGeAlD
Antipyrine—CYP2B6—vagina—urinary bladder cancer	0.000537	0.00924	CbGeAlD
Antipyrine—PTGS1—female reproductive system—urinary bladder cancer	0.000537	0.00923	CbGeAlD
Antipyrine—PTGS2—female reproductive system—urinary bladder cancer	0.000513	0.00882	CbGeAlD
Antipyrine—PTGS1—vagina—urinary bladder cancer	0.000486	0.00835	CbGeAlD
Antipyrine—PTGS2—vagina—urinary bladder cancer	0.000464	0.00798	CbGeAlD
Antipyrine—CYP3A4—female reproductive system—urinary bladder cancer	0.000449	0.00771	CbGeAlD
Antipyrine—CYP2D6—female reproductive system—urinary bladder cancer	0.000441	0.00759	CbGeAlD
Antipyrine—PTGS1—lymph node—urinary bladder cancer	0.000314	0.0054	CbGeAlD
Antipyrine—PTGS2—lymph node—urinary bladder cancer	0.0003	0.00516	CbGeAlD
Antipyrine—CYP2C8—Metabolism—NAT2—urinary bladder cancer	1.99e-05	0.000161	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—RRM2—urinary bladder cancer	1.99e-05	0.000161	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—NQO1—urinary bladder cancer	1.99e-05	0.000161	CbGpPWpGaD
Antipyrine—PTGS2—Disease—JAG1—urinary bladder cancer	1.99e-05	0.000161	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.97e-05	0.00016	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	1.97e-05	0.000159	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—TYMP—urinary bladder cancer	1.97e-05	0.000159	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—ENO2—urinary bladder cancer	1.96e-05	0.000158	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—HPGDS—urinary bladder cancer	1.96e-05	0.000158	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	1.95e-05	0.000158	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—NAT1—urinary bladder cancer	1.95e-05	0.000158	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.95e-05	0.000158	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.93e-05	0.000156	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	1.92e-05	0.000155	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—GSTT1—urinary bladder cancer	1.9e-05	0.000154	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.89e-05	0.000153	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—ENO2—urinary bladder cancer	1.88e-05	0.000152	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—HPGDS—urinary bladder cancer	1.88e-05	0.000152	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—NQO1—urinary bladder cancer	1.88e-05	0.000152	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.87e-05	0.000151	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—ENO2—urinary bladder cancer	1.84e-05	0.000149	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—HPGDS—urinary bladder cancer	1.84e-05	0.000149	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—GSTT1—urinary bladder cancer	1.83e-05	0.000148	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—TYMP—urinary bladder cancer	1.81e-05	0.000146	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.8e-05	0.000146	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—TYMP—urinary bladder cancer	1.79e-05	0.000145	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—GSTT1—urinary bladder cancer	1.79e-05	0.000145	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	1.79e-05	0.000145	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—NAT2—urinary bladder cancer	1.78e-05	0.000144	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.72e-05	0.000139	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—RRM2—urinary bladder cancer	1.72e-05	0.000139	CbGpPWpGaD
Antipyrine—CYP2C18—Metabolism—PPARG—urinary bladder cancer	1.7e-05	0.000137	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.68e-05	0.000136	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—GSTP1—urinary bladder cancer	1.66e-05	0.000134	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—NAT2—urinary bladder cancer	1.64e-05	0.000132	CbGpPWpGaD
Antipyrine—CYP2C18—Metabolism—CREBBP—urinary bladder cancer	1.63e-05	0.000132	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—NAT2—urinary bladder cancer	1.62e-05	0.000131	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	1.61e-05	0.00013	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.61e-05	0.00013	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—ENO2—urinary bladder cancer	1.59e-05	0.000129	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	1.59e-05	0.000129	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.59e-05	0.000128	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—NQO1—urinary bladder cancer	1.58e-05	0.000128	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—GSTP1—urinary bladder cancer	1.57e-05	0.000127	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	1.55e-05	0.000125	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—TYMS—urinary bladder cancer	1.54e-05	0.000125	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.54e-05	0.000124	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—RRM2—urinary bladder cancer	1.54e-05	0.000124	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—TYMP—urinary bladder cancer	1.53e-05	0.000124	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—NCOR1—urinary bladder cancer	1.53e-05	0.000123	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—GSTM1—urinary bladder cancer	1.53e-05	0.000123	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.52e-05	0.000123	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	1.52e-05	0.000123	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—NQO1—urinary bladder cancer	1.52e-05	0.000123	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—NQO1—urinary bladder cancer	1.49e-05	0.00012	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	1.48e-05	0.00012	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.47e-05	0.000119	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—GPX1—urinary bladder cancer	1.46e-05	0.000118	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—TYMS—urinary bladder cancer	1.46e-05	0.000118	CbGpPWpGaD
Antipyrine—PTGS2—Disease—NCOR1—urinary bladder cancer	1.45e-05	0.000117	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—GSTM1—urinary bladder cancer	1.44e-05	0.000117	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—NCOR1—urinary bladder cancer	1.44e-05	0.000117	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—ERCC2—urinary bladder cancer	1.43e-05	0.000116	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—ENO2—urinary bladder cancer	1.42e-05	0.000115	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	1.42e-05	0.000115	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.41e-05	0.000114	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—RRM2—urinary bladder cancer	1.41e-05	0.000114	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—RRM2—urinary bladder cancer	1.4e-05	0.000113	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—NAT2—urinary bladder cancer	1.39e-05	0.000112	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—GPX1—urinary bladder cancer	1.38e-05	0.000112	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	1.38e-05	0.000112	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.36e-05	0.00011	CbGpPWpGaD
Antipyrine—PTGS2—Disease—ERCC2—urinary bladder cancer	1.36e-05	0.00011	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—ERCC2—urinary bladder cancer	1.36e-05	0.00011	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—MTHFR—urinary bladder cancer	1.35e-05	0.000109	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.34e-05	0.000108	CbGpPWpGaD
Antipyrine—CYP2C18—Metabolism—PTGS2—urinary bladder cancer	1.33e-05	0.000108	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—GSTP1—urinary bladder cancer	1.32e-05	0.000107	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—ENO2—urinary bladder cancer	1.31e-05	0.000106	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	1.31e-05	0.000106	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—ENO2—urinary bladder cancer	1.3e-05	0.000105	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	1.3e-05	0.000105	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.29e-05	0.000104	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—NQO1—urinary bladder cancer	1.29e-05	0.000104	CbGpPWpGaD
Antipyrine—PTGS2—Disease—MTHFR—urinary bladder cancer	1.28e-05	0.000103	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.27e-05	0.000103	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—MTHFR—urinary bladder cancer	1.27e-05	0.000103	CbGpPWpGaD
Antipyrine—PTGS2—Disease—TERT—urinary bladder cancer	1.27e-05	0.000103	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	1.27e-05	0.000103	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—GSTP1—urinary bladder cancer	1.27e-05	0.000102	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	1.26e-05	0.000102	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.25e-05	0.000101	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—GSTP1—urinary bladder cancer	1.24e-05	0.0001	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.24e-05	0.0001	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—TYMS—urinary bladder cancer	1.22e-05	9.91e-05	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—NCOR1—urinary bladder cancer	1.21e-05	9.79e-05	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—GSTM1—urinary bladder cancer	1.21e-05	9.79e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—RRM2—urinary bladder cancer	1.2e-05	9.68e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—TYMP—urinary bladder cancer	1.18e-05	9.57e-05	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—TYMS—urinary bladder cancer	1.18e-05	9.52e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—FGFR3—urinary bladder cancer	1.17e-05	9.46e-05	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—GSTM1—urinary bladder cancer	1.16e-05	9.41e-05	CbGpPWpGaD
Antipyrine—CYP2C18—Metabolism—PTEN—urinary bladder cancer	1.16e-05	9.41e-05	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—NCOR1—urinary bladder cancer	1.16e-05	9.41e-05	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—GPX1—urinary bladder cancer	1.16e-05	9.38e-05	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—TYMS—urinary bladder cancer	1.15e-05	9.33e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—NQO1—urinary bladder cancer	1.15e-05	9.28e-05	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—NCOR1—urinary bladder cancer	1.14e-05	9.22e-05	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—GSTM1—urinary bladder cancer	1.14e-05	9.22e-05	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—ERCC2—urinary bladder cancer	1.14e-05	9.21e-05	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—GPX1—urinary bladder cancer	1.11e-05	9.01e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.11e-05	9e-05	CbGpPWpGaD
Antipyrine—CYP2C18—Metabolism—EP300—urinary bladder cancer	1.11e-05	8.98e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—ENO2—urinary bladder cancer	1.11e-05	8.97e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	1.11e-05	8.97e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.1e-05	8.92e-05	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—ERCC2—urinary bladder cancer	1.09e-05	8.85e-05	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—PPARG—urinary bladder cancer	1.09e-05	8.84e-05	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—GPX1—urinary bladder cancer	1.09e-05	8.83e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.09e-05	8.8e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	1.08e-05	8.7e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	1.07e-05	8.67e-05	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—ERCC2—urinary bladder cancer	1.07e-05	8.67e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.07e-05	8.66e-05	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—MTHFR—urinary bladder cancer	1.07e-05	8.65e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.06e-05	8.57e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—NQO1—urinary bladder cancer	1.06e-05	8.53e-05	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—CREBBP—urinary bladder cancer	1.05e-05	8.49e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—NQO1—urinary bladder cancer	1.05e-05	8.46e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.04e-05	8.39e-05	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—PPARG—urinary bladder cancer	1.03e-05	8.36e-05	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—MTHFR—urinary bladder cancer	1.03e-05	8.32e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.01e-05	8.21e-05	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—MTHFR—urinary bladder cancer	1.01e-05	8.15e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—TYMS—urinary bladder cancer	9.97e-06	8.06e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—CREBBP—urinary bladder cancer	9.95e-06	8.05e-05	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—CREBBP—urinary bladder cancer	9.93e-06	8.03e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	9.85e-06	7.97e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	9.85e-06	7.97e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	9.71e-06	7.85e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	9.57e-06	7.74e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—GPX1—urinary bladder cancer	9.43e-06	7.63e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	9.26e-06	7.49e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	9.26e-06	7.49e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—RRM2—urinary bladder cancer	9.24e-06	7.47e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—RHOA—urinary bladder cancer	9e-06	7.28e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—NQO1—urinary bladder cancer	8.94e-06	7.23e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—TYMS—urinary bladder cancer	8.9e-06	7.19e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	8.85e-06	7.16e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	8.8e-06	7.12e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	8.79e-06	7.11e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	8.79e-06	7.11e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	8.72e-06	7.06e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	8.71e-06	7.04e-05	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—PPARG—urinary bladder cancer	8.68e-06	7.02e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	8.67e-06	7.01e-05	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—PTGS2—urinary bladder cancer	8.6e-06	6.95e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—ENO2—urinary bladder cancer	8.56e-06	6.92e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	8.56e-06	6.92e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	8.44e-06	6.83e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—GPX1—urinary bladder cancer	8.42e-06	6.81e-05	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—PPARG—urinary bladder cancer	8.34e-06	6.74e-05	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—CREBBP—urinary bladder cancer	8.33e-06	6.74e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—ERBB2—urinary bladder cancer	8.33e-06	6.74e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	8.3e-06	6.71e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	8.27e-06	6.69e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—TYMS—urinary bladder cancer	8.18e-06	6.62e-05	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—PPARG—urinary bladder cancer	8.17e-06	6.61e-05	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—PTGS2—urinary bladder cancer	8.13e-06	6.58e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—TYMS—urinary bladder cancer	8.11e-06	6.56e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	8.09e-06	6.54e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	8.09e-06	6.54e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	8.02e-06	6.48e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	8.02e-06	6.48e-05	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—CREBBP—urinary bladder cancer	8.01e-06	6.48e-05	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—CREBBP—urinary bladder cancer	7.85e-06	6.35e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	7.77e-06	6.29e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—GPX1—urinary bladder cancer	7.74e-06	6.26e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—GPX1—urinary bladder cancer	7.68e-06	6.21e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	7.6e-06	6.15e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	7.56e-06	6.12e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	7.54e-06	6.1e-05	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—PTEN—urinary bladder cancer	7.5e-06	6.06e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	7.46e-06	6.03e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	7.21e-06	5.83e-05	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—EP300—urinary bladder cancer	7.15e-06	5.78e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	7.15e-06	5.78e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—CDKN1A—urinary bladder cancer	7.12e-06	5.76e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—PTEN—urinary bladder cancer	7.11e-06	5.75e-05	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—PTEN—urinary bladder cancer	7.09e-06	5.73e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	7.09e-06	5.73e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—PPARG—urinary bladder cancer	7.06e-06	5.71e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—TYMS—urinary bladder cancer	6.93e-06	5.61e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—NQO1—urinary bladder cancer	6.9e-06	5.58e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	6.85e-06	5.54e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	6.85e-06	5.54e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	6.78e-06	5.49e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—EP300—urinary bladder cancer	6.78e-06	5.48e-05	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—EP300—urinary bladder cancer	6.76e-06	5.47e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—SRC—urinary bladder cancer	6.59e-06	5.33e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—GPX1—urinary bladder cancer	6.56e-06	5.31e-05	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—PTGS2—urinary bladder cancer	6.56e-06	5.31e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	6.44e-06	5.21e-05	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—PTGS2—urinary bladder cancer	6.42e-06	5.2e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—PPARG—urinary bladder cancer	6.3e-06	5.1e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	6.05e-06	4.9e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	6.05e-06	4.9e-05	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—PTEN—urinary bladder cancer	5.95e-06	4.81e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—MYC—urinary bladder cancer	5.91e-06	4.78e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—PPARG—urinary bladder cancer	5.8e-06	4.69e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—EGFR—urinary bladder cancer	5.78e-06	4.67e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	5.75e-06	4.65e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—PPARG—urinary bladder cancer	5.75e-06	4.65e-05	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—PTEN—urinary bladder cancer	5.72e-06	4.63e-05	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—EP300—urinary bladder cancer	5.68e-06	4.59e-05	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—PTEN—urinary bladder cancer	5.6e-06	4.53e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	5.57e-06	4.5e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	5.55e-06	4.49e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	5.52e-06	4.46e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—KRAS—urinary bladder cancer	5.46e-06	4.41e-05	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—EP300—urinary bladder cancer	5.46e-06	4.41e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—TYMS—urinary bladder cancer	5.35e-06	4.33e-05	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—EP300—urinary bladder cancer	5.34e-06	4.32e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	5.29e-06	4.28e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	5.29e-06	4.28e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—GPX1—urinary bladder cancer	5.06e-06	4.1e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	4.97e-06	4.02e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	4.96e-06	4.01e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—PPARG—urinary bladder cancer	4.91e-06	3.97e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—PTEN—urinary bladder cancer	4.84e-06	3.92e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	4.72e-06	3.81e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	4.67e-06	3.78e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—HRAS—urinary bladder cancer	4.64e-06	3.75e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—EP300—urinary bladder cancer	4.62e-06	3.74e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	4.56e-06	3.69e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	4.52e-06	3.66e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—PTEN—urinary bladder cancer	4.32e-06	3.5e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—EP300—urinary bladder cancer	4.12e-06	3.33e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—PTEN—urinary bladder cancer	3.98e-06	3.22e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—PTEN—urinary bladder cancer	3.94e-06	3.19e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	3.86e-06	3.12e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—EP300—urinary bladder cancer	3.79e-06	3.07e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—PPARG—urinary bladder cancer	3.79e-06	3.06e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—EP300—urinary bladder cancer	3.76e-06	3.04e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	3.64e-06	2.94e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—PTEN—urinary bladder cancer	3.37e-06	2.72e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—EP300—urinary bladder cancer	3.21e-06	2.6e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	2.98e-06	2.41e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—PTEN—urinary bladder cancer	2.6e-06	2.1e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—EP300—urinary bladder cancer	2.48e-06	2.01e-05	CbGpPWpGaD
